抗菌藥物敏感性測試市場規模、佔有率和成長分析（按產品、類型、方法、應用、最終用戶和地區分類）—2026-2033年產業預測

預計到 2024 年，抗生素敏感性測試市場規模將達到 46.3 億美元，到 2025 年將達到 48.7 億美元，到 2033 年將達到 73.1 億美元，在預測期（2026-2033 年）內，複合年成長率為 5.2%。

抗菌藥物敏感性檢測 (AST) 市場在醫療保健領域發揮著至關重要的作用，尤其是在感染疾病控制和微生物學發展方面。其主要促進因素包括抗生素抗藥性細菌的日益普及和全球感染疾病的快速成長，這些因素推動了對精準診斷技術的需求。自動化和分子方法等創新正在提高 AST 的準確性和有效性。不斷湧現的市場參與企業也為醫療保健機構提供了多樣化的檢測選擇。然而，AST 技術高成本、缺乏標準化以及操作流程複雜等挑戰，尤其是在低收入地區，可能會阻礙市場成長。儘管如此，就地檢驗)的興起和再生醫學的進步正在為更方便的 AST 解決方案和市場擴張創造機會。

抗菌藥物敏感性測試市場促進因素

抗菌藥物抗藥性（AMR）問題日益嚴重，已成為全球重大的健康威脅，促使衛生組織和監管機構將可靠的抗菌藥物敏感性試驗（AST）作為優先事項，以監測抗藥性趨勢。這項工作有助於制定治療策略並促進合理使用抗生素。此外，由於旅行增加、都市化和人口成長等因素，感染疾病病例不斷增加，凸顯了高效診斷和治療方法方案的迫切需求。因此，人們越來越需要有效可靠的抗菌藥物敏感性試驗解決方案，以應對抗藥性病原體帶來的威脅，並確保患者照護。

限制抗菌藥物敏感性測試市場的因素

在某些地區，尤其是在中低收入國家，人們對抗菌藥物敏感性試驗（AST）的益處普遍缺乏認知。此外，實驗室技術人員在現代檢測技術方面的訓練不足也會阻礙AST實務的有效實施。同時，診斷設備和解決方案的監管環境複雜且耗時，為創新的AST技術及時上市帶來了挑戰。嚴格的監管要求會進一步加劇這些延誤，並最終限制受影響地區重要AST調查方法的可近性和應用。

抗菌藥物敏感性測試市場趨勢

抗菌藥物敏感性檢測市場的一個顯著趨勢是快速檢測技術的應用，這些技術能夠顯著縮短獲得檢測結果所需的時間。質譜分析、分子診斷和自動化系統等技術正引領這項變革，使醫療服務提供者能夠快速識別病原體及其藥物敏感性譜。這項進步在急診護理環境中尤其重要，因為及時介入能夠顯著改善患者的預後。隨著醫療機構越來越重視治療決策的效率和準確性，對快速抗菌藥物敏感性檢測解決方案的需求預計將會成長，從而推動該領域的創新和投資。

目錄

介紹

• 調查目標
• 調查範圍
• 定義

調查方法

• 資訊收集
• 二手資料和一手資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分市場機會分析

市場動態與展望

• 市場規模
• 市場動態
  • 促進因素和機遇
  • 限制與挑戰
• 波特分析

關鍵市場考察

• 關鍵成功因素
• 競爭程度
• 關鍵投資機會
• 市場生態系統
• 市場吸引力指數（2025）
• PESTEL 分析
• 總體經濟指標
• 價值鏈分析
• 定價分析
• 案例研究分析
• 專利分析

全球抗菌藥物敏感性測試市場規模（按產品和複合年成長率分類）（2026-2033 年）

• 消耗品
  • 培養基
  • 磁化率測試盤
  • MIC 試紙
  • 藥敏試驗平板
• 實驗設備
  • 自動化實驗室設備
  • 分子診斷系統
• 實驗室耗材

全球抗菌藥物敏感性測試市場規模（按類型和複合年成長率分類）（2026-2033 年）

• 抗菌藥物敏感性試驗
• 抗真菌藥物敏感性試驗
• 抗寄生蟲藥物敏感性試驗
• 抗病毒藥物敏感性試驗

全球抗菌藥物敏感性測試市場規模（按方法和複合年成長率分類）（2026-2033 年）

• 定性方法
  • 自動化AST方法
  • 紙錠擴散法
  • 瓊脂稀釋法
  • 基因分型方法
• 定量方法
  • ETEST 方法
  • 肉湯微量稀釋法

全球抗菌藥物敏感性測試市場規模（按應用領域及複合年成長率分類）（2026-2033 年）

• 臨床診斷
• 藥物發現與開發
• 流行病學
• 其他用途

全球抗菌藥物敏感性測試市場規模（按最終用戶分類）及複合年成長率（2026-2033 年）

• 醫院和診斷中心
• 製藥和生物技術公司
• 學術和研究機構
• 臨床研究所

全球抗菌藥物敏感性測試市場規模（按地區分類）及複合年成長率（2026-2033 年）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 亞太其他地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地區
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前五大公司對比
• 主要企業的市場定位（2025 年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市佔率分析（2025 年）
• 主要企業公司簡介
  • 公司詳情
  • 產品系列分析
  • 依業務板塊進行公司股票分析
  • 2023-2025年營收年比比較

主要企業簡介

• Thermo Fisher Scientific Inc.（US）
• Bio-Rad Laboratories, Inc.（US）
• Danaher Corporation（US）
• Becton, Dickinson and Company（US）
• bioMerieux SA（France）
• Roche Diagnostics（Switzerland）
• Abbott Laboratories（US）
• Bruker Corporation（US）
• Merck KGaA（Germany）
• Agilent Technologies, Inc.（US）
• ConvaTec Group plc（UK）
• HiMedia Laboratories Pvt. Ltd.（India）
• Liofilchem srl（Italy）
• Accelerate Diagnostics, Inc.（US）
• Creative Diagnostics（US）
• Bio-Rad Laboratories（US）
• Synbiosis（UK）
• QIAGEN NV（Germany）

結論與建議

Antimicrobial Susceptibility Testing Market size was valued at USD 4.63 Billion in 2024 and is poised to grow from USD 4.87 Billion in 2025 to USD 7.31 Billion by 2033, growing at a CAGR of 5.2% during the forecast period (2026-2033).

The antimicrobial susceptibility testing (AST) market is integral to healthcare, particularly in managing infectious diseases and advancing microbiology. Driving factors include the escalating prevalence of antibiotic-resistant bacteria and a global surge in infectious diseases, which heightens the demand for accurate diagnostic technologies. Innovations like automation and molecular methods are enhancing AST precision and effectiveness. The growing number of market players also presents diverse testing options for healthcare providers. However, challenges such as high costs of AST technologies, lack of standardization, and procedural complexities may hinder market growth, particularly in lower-income regions. Nonetheless, the increasing trend towards point-of-care testing, along with advancements in regenerative medicine, opens opportunities for more user-friendly AST solutions and market expansion.

Top-down and bottom-up approaches were used to estimate and validate the size of the Antimicrobial Susceptibility Testing market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Antimicrobial Susceptibility Testing Market Segments Analysis

Global Antimicrobial Susceptibility Testing Market is segmented by Product, Type, Method, Application, End User and region. Based on Product, the market is segmented into Consumables, Lab Instruments and Lab Disposables. Based on Type, the market is segmented into Antibacterial Susceptibility Testing, Antifungal Susceptibility Testing, Antiparasitic Susceptibility Testing and Antiviral Susceptibility Testing. Based on Method, the market is segmented into Qualitative Methods and Quantitative Methods. Based on Application, the market is segmented into Clinical Diagnostics, Drug Discovery & Development, Epidemiology and Other Applications. Based on End User, the market is segmented into Hospitals & Diagnostic Centers, Pharmaceutical & Biotechnology Companies, Academic & Research Institutes and Clinical Research Organizations. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Antimicrobial Susceptibility Testing Market

The escalating issue of antimicrobial resistance (AMR) poses a significant challenge to global health, prompting health organizations and authorities to prioritize robust antimicrobial susceptibility testing (AST) to monitor resistance trends. This focus aids in informing treatment strategies and promoting prudent antibiotic usage. Additionally, the rise in infectious disease cases, fueled by elements such as increased travel, urbanization, and population growth, underscores the urgent need for efficient diagnosis and treatment options. Consequently, there is a heightened demand for effective and dependable AST solutions to combat the threats posed by resistant pathogens and ensure optimal patient care.

Restraints in the Antimicrobial Susceptibility Testing Market

In certain regions, particularly middle-income and low-income countries, there is a significant lack of awareness regarding the advantages of Antimicrobial Susceptibility Testing (AST). Additionally, inadequate training for laboratory personnel in the latest testing techniques can hinder the effective implementation of AST practices. Furthermore, the regulatory landscape concerning diagnostic instruments and solutions can be intricate and time-consuming, leading to challenges in the timely market introduction of innovative AST technologies. Stringent regulatory requirements may further exacerbate these delays, ultimately limiting the accessibility and utilization of essential AST methodologies in affected regions.

Market Trends of the Antimicrobial Susceptibility Testing Market

The Antimicrobial Susceptibility Testing market is witnessing a notable trend toward the adoption of rapid testing techniques that significantly reduce the time needed to obtain results. Technologies such as mass spectrometry, molecular diagnostics, and automated systems are at the forefront of this transformation, enabling healthcare providers to swiftly identify pathogens and their susceptibility profiles. This advancement is particularly critical in urgent care scenarios, where timely interventions can greatly enhance patient outcomes. As healthcare environments increasingly prioritize efficiency and precision in treatment decisions, the demand for rapid testing solutions in antimicrobial susceptibility is expected to expand, driving innovation and investment in this sector.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Case Study Analysis
• Patent Analysis

Global Antimicrobial Susceptibility Testing Market Size by Product & CAGR (2026-2033)

• Market Overview
• Consumables
  • Culture & Growth Media
  • Susceptibility Testing Disks
  • Mic Strips
  • Susceptibility Testing Plates
• Lab Instruments
  • Automated Laboratory Instruments
  • Molecular Diagnostics Systems
• Lab Disposables

Global Antimicrobial Susceptibility Testing Market Size by Type & CAGR (2026-2033)

• Market Overview
• Antibacterial Susceptibility Testing
• Antifungal Susceptibility Testing
• Antiparasitic Susceptibility Testing
• Antiviral Susceptibility Testing

Global Antimicrobial Susceptibility Testing Market Size by Method & CAGR (2026-2033)

• Market Overview
• Qualitative Methods
  • Automated Ast
  • Disk Diffusion
  • Agar Dilution
  • Genotypic Method
• Quantitative Methods
  • ETEST Method
  • Broth Macrodilution

Global Antimicrobial Susceptibility Testing Market Size by Application & CAGR (2026-2033)

• Market Overview
• Clinical Diagnostics
• Drug Discovery & Development
• Epidemiology
• Other Applications

Global Antimicrobial Susceptibility Testing Market Size by End User & CAGR (2026-2033)

• Market Overview
• Hospitals & Diagnostic Centers
• Pharmaceutical & Biotechnology Companies
• Academic & Research Institutes
• Clinical Research Organizations

Global Antimicrobial Susceptibility Testing Market Size & CAGR (2026-2033)

• North America (Product, Type, Method, Application, End User)
  • US
  • Canada
• Europe (Product, Type, Method, Application, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Type, Method, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Type, Method, Application, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Type, Method, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Thermo Fisher Scientific Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• bioMerieux SA (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Roche Diagnostics (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bruker Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ConvaTec Group plc (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• HiMedia Laboratories Pvt. Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Liofilchem s.r.l. (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Accelerate Diagnostics, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Creative Diagnostics (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Synbiosis (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• QIAGEN N.V. (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations